Exact Mass: 466.2726

Cephaeline

C28H38N2O4 (466.2831)

Cephaeline is a pyridoisoquinoline comprising emetam having a hydroxy group at the 6-position and methoxy substituents at the 7-, 10- and 11-positions. It derives from a hydride of an emetan. Cephaeline is a natural product found in Dorstenia psilurus, Pogonopus tubulosus, and other organisms with data available. Cephaeline is an alkaloid compound that belongs to the isoquinoline alkaloid family. It is naturally found in certain plant species, particularly those of the Cephalotaxus genus, which includes trees and shrubs native to East Asia and the Himalayas. Cephaeline is known for its pharmacological properties and has been the subject of various studies for its potential therapeutic applications. Chemically, cephaeline has a complex structure characterized by an isoquinoline core with additional functional groups attached. It is classified as a monoterpenoid indole alkaloid, reflecting its biosynthetic origin from the amino acid tryptophan. The presence of these functional groups contributes to its biological activity and pharmacological effects. In terms of its physical properties, cephaeline is typically a crystalline solid with a defined melting point. It is slightly soluble in water but more soluble in organic solvents, which is common for alkaloids of its class. The exact color and solubility characteristics can vary depending on the presence of impurities or derivatives. Cephaeline has been of interest in the field of pharmacognosy and drug discovery due to its potential therapeutic effects, including anti-cancer, anti-inflammatory, and neuroprotective properties. However, further research is needed to fully understand its mechanisms of action and potential uses in medicine. Annotation level-1 (-)-Cephaeline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=483-17-0 (retrieved 2024-07-12) (CAS RN: 483-17-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Androsterone glucuronide

C25H38O8 (466.2567)

Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522) [HMDB] Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

5β-Androstan-3α-ol-17-One Glucosiduronate

C25H38O8 (466.2567)

Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Etiocholanolone glucuronide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=3602-09-3 (retrieved 2024-06-29) (CAS RN: 3602-09-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

5-alpha-Dihydrotestosterone glucuronide

C25H38O8 (466.2567)

5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

1-eicosanoyl-glycero-3-phosphate

C23H47O7P (466.3059)

1-eicosanoyl-glycero-3-phosphate is also known as LPA(20:0/0:0). 1-eicosanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-eicosanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

LysoPA(i-20:0/0:0)

C23H47O7P (466.3059)

LysoPA(i-20:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-20:0/0:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

5alpha-Androstan-17beta-ol-3-one glucosiduronate

C25H38O8 (466.2567)

Acetildenafil

C25H34N6O3 (466.2692)

Cephaeline

C28H38N2O4 (466.2831)

Mutant IDH1 inhibitor

C25H34N6O3 (466.2692)

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C25H38O8 (466.2567)

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

C25H38O8 (466.2567)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H38O8 (466.2567)

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

C25H38O8 (466.2567)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Ramiflorine A

C30H34N4O (466.2732)

Mniopetal B

C25H38O8 (466.2567)

Australin B

C26H42O7 (466.293)

(-)-5alpha-(12-Cytisinylmethyl)-6alpha-hydroxylupanine

C27H38N4O3 (466.2944)

Rhodioloside E

C21H38O11 (466.2414)

Neocephaeline

C28H38N2O4 (466.2831)

Lemnaloside D

C26H42O7 (466.293)

N-(12-Amino-4,9-diazadodecan-1-yl)-2-[[(2,4-dihydroxyphenyl)acetyl]amino]succinamide

C22H38N6O5 (466.2904)

VIRESCENOSIDE B

C26H42O7 (466.293)

Kleinioxanthrone 2

C29H38O5 (466.2719)

Mniopetal D

C25H38O8 (466.2567)

Australin C

C26H42O7 (466.293)

Chabrolonaphthoquinone B

C29H38O5 (466.2719)

Leucasdin A

C25H38O8 (466.2567)

acetildenafil

C25H34N6O3 (466.2692)

D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Acetylvardenafil

C25H34N6O3 (466.2692)

Dimethyl acetildenafil

C25H34N6O3 (466.2692)

1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N2-methylalaninamide

C23H38N4O6 (466.2791)

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-11-ol|Usambaridin Br|Usambaridine Br

C30H34N4O (466.2732)

10-Hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-10-ol|18-Dehydro-10-hydroxynigritanin

C30H34N4O (466.2732)

(11alpha,12alpha)-4-demethyl-11,12-epoxy-3,13-dihydroxy-2-oxoursa-3,20(30)-diene-28-oic acid gamma-lactone|adenanthusone

C29H38O5 (466.2719)

C29H38O5

C29H38O5 (466.2719)

Withanicandrin

C29H38O5 (466.2719)

Isovaleryl-coladonin

C29H38O5 (466.2719)

(1S,2S,3R,4R,6R)-diangeloyloxy-3,4-epoxy-2,10,11-trihydroxybisabol-7(14)-ene|1beta,8-diangeloyloxy-3beta,4beta-epoxy-2beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2567)

8alpha-hydroxylabda-13(16),14-dien-19-yl (Z)-4-hydroxycinnamate

C29H38O5 (466.2719)

2,22beta-dihydroxy-3-methoxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione

C29H38O5 (466.2719)

3-methyl-23-hydroxy-6-oxo-tingenol|3-O-methyl-23-hydroxy-6-oxotingenol

C29H38O5 (466.2719)

hirsutalin H

C26H42O7 (466.293)

klysimplexin A

C26H42O7 (466.293)

Asebotoxin IX

C25H38O8 (466.2567)

ptychantin L

C26H42O7 (466.293)

C27H34N2O5

C27H34N2O5 (466.2468)

16(R)-6alpha,11beta-dihydroxy-17-methoxy-3beta,7beta-diacetoxy-ent-kaur-15-one|xindongnin G

C25H38O8 (466.2567)

C26H42O7

C26H42O7 (466.293)

14,15,18-triacetyl-trinertetrol

C26H42O7 (466.293)

clerodinin A|clerodinin B|lupulin D|O15-De-Et,O15-Methyl,15-Epimer-Clerodinin C

C25H38O8 (466.2567)

20-Hydroxyecdysone

C26H42O7 (466.293)

(1R*,2R*,3E,7E,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol

C26H42O7 (466.293)

11,12-Di-O-acetyl-marsectohexol|11,12-di-O-acetylmarsectohexol|11.12-Di-O-acetyl-marsectohexol|12-O-acetyllanceogenin

C25H38O8 (466.2567)

(E)-3,7-dimethyl-1-O-6)-beta-D-glucopyranosyl>-oct-2-en-7-ol

C21H38O11 (466.2414)

klysimplexin C

C26H42O7 (466.293)

methylcaribaeorane

C28H38N2O4 (466.2831)

Asebotoxin-IX

C25H38O8 (466.2567)

1,6,9-trihydroxy-3-(1-hydroxy-1-methylethyl)-10-isobutyryl-5,5-dimethyl-8-(3-methylbut-2-enyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione|garcinielliptone HF

C25H38O8 (466.2567)

Antiostatin B5

C27H38N4O3 (466.2944)

(1beta,2beta,3beta,4beta,6beta)-3,4-epoxybisabol-7(14)-ene-1,2,8,10,11-pentol 2,10-diangelate|(2Z)-2-methylbut-2-enoic acid (1RS,2SR,3SR,4RS,6RS)-4-(2,5-dihydroxy-5-methyl-1-methylene-4-{[(2Z)-2-methyl-1-oxobut-2-en-1-yl]oxy}hexyl)-3-hydroxy-1-methyl-7-oxabicyclo[4.1.0]hept-2-yl ester

C25H38O8 (466.2567)

6-acetoxy litophynin E

C26H42O7 (466.293)

cladieunicellin I

C26H42O7 (466.293)

4-epi-aubergenone 11-O-2,3-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2567)

4-epi-aubergenone 11-O-2,4-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2567)

2beta,8-diangeloyloxy-3beta,4beta-epoxy-1beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2567)

2beta,8-diangeloyloxy-1beta,3beta,4alpha,11-tetrahydroxybisabol-7(14),9-diene

C25H38O8 (466.2567)

farneside A

C24H38N2O7 (466.2679)

(11S,12S)-4-methyl-11,12-epoxy-2-hydroxy-3-oxoursa-1,4-dine-28-oic acid-gamma-lactone|ulmoidol A

C29H38O5 (466.2719)

litophynin I monoacetate

C26H42O7 (466.293)

simplexin P

C26H42O7 (466.293)

creticoside A

C26H42O7 (466.293)

23-Nor-6-oxopristimerol

C29H38O5 (466.2719)

(rel-5S,6R,8R,9R,10S,13S,15R)-6-acetoxy-9,13:15,16-diepoxy-15-methoxylabdane|3alpha,8beta-diacetoxy-9,13;15,16-diepoxy-15beta-methoxylabdan-7-one|leosibirinone A

C25H38O8 (466.2567)

Cylindramide

C27H34N2O5 (466.2468)

cryptosphaerolide

C26H42O7 (466.293)

alpha-eudesmol-beta-D-glucopyranoside-6-O-tiglate

C26H42O7 (466.293)

klysimplexin S

C26H42O7 (466.293)

erinacine J

C25H38O8 (466.2567)

4,5,6-Tri-O-acetyl hygrophorone B14

C26H42O7 (466.293)

11-hydroxyusambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-18-en-12-ol|Usambaridin Vi

C30H34N4O (466.2732)

pachycladin B

C26H42O7 (466.293)

Wilforol A

C29H38O5 (466.2719)

Wilforol A is a pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii. It has a role as a plant metabolite. It is a pentacyclic triterpenoid, a hydroxy monocarboxylic acid, a member of catechols, a cyclic terpene ketone and an enone. Wilforol A is a natural product found in Tripterygium hypoglaucum, Tripterygium wilfordii, and Celastrus orbiculatus with data available. A pentacyclic triterpenoid with formula C29H38O5, originally isolated from the stems of Tripterygium regelii.

Lindokaurenosid C

C26H42O7 (466.293)

5??,6??-Epoxy-4??-hydroxy-1-oxo-witha-2,16,24-trienolide

C29H38O5 (466.2719)

Calocin

C26H42O7 (466.293)

(2S)-OMPT

C22H43O6PS (466.2518)

6-Oxo-23-norpristimerol

C29H38O5 (466.2719)

C23H38N4O6_1-[(2E,4E)-6,7-Dihydroxy-2,4-octadienoyl]prolyl-N-methylvalyl-N~2~-methylalaninamide

C23H38N4O6 (466.2791)

10-hydroxyusambarine

C30H34N4O (466.2732)

11-hydroxyusambarine

C30H34N4O (466.2732)

Ala Ile Thr Tyr

C22H34N4O7 (466.2427)

Ala Ile Tyr Thr

C22H34N4O7 (466.2427)

Ala Leu Thr Tyr

C22H34N4O7 (466.2427)

Ala Leu Tyr Thr

C22H34N4O7 (466.2427)

Ala Thr Ile Tyr

C22H34N4O7 (466.2427)

Ala Thr Leu Tyr

C22H34N4O7 (466.2427)

Ala Thr Tyr Ile

C22H34N4O7 (466.2427)

Ala Thr Tyr Leu

C22H34N4O7 (466.2427)

Ala Tyr Ile Thr

C22H34N4O7 (466.2427)

Ala Tyr Leu Thr

C22H34N4O7 (466.2427)

Ala Tyr Thr Ile

C22H34N4O7 (466.2427)

Ala Tyr Thr Leu

C22H34N4O7 (466.2427)

Phe Ile Ser Thr

C22H34N4O7 (466.2427)

Phe Ile Thr Ser

C22H34N4O7 (466.2427)

Phe Leu Ser Thr

C22H34N4O7 (466.2427)

Phe Leu Thr Ser

C22H34N4O7 (466.2427)

Phe Ser Ile Thr

C22H34N4O7 (466.2427)

Phe Ser Leu Thr

C22H34N4O7 (466.2427)

Phe Ser Thr Ile

C22H34N4O7 (466.2427)

Phe Ser Thr Leu

C22H34N4O7 (466.2427)

Phe Thr Ile Ser

C22H34N4O7 (466.2427)

Phe Thr Leu Ser

C22H34N4O7 (466.2427)

Phe Thr Ser Ile

C22H34N4O7 (466.2427)

Phe Thr Ser Leu

C22H34N4O7 (466.2427)

Phe Thr Thr Val

C22H34N4O7 (466.2427)

Phe Thr Val Thr

C22H34N4O7 (466.2427)

Phe Val Thr Thr

C22H34N4O7 (466.2427)

His Ile Pro Thr

C21H34N6O6 (466.254)

His Ile Thr Pro

C21H34N6O6 (466.254)

His Ile Val Val

C22H38N6O5 (466.2904)

His Leu Pro Thr

C21H34N6O6 (466.254)

His Leu Thr Pro

C21H34N6O6 (466.254)

His Leu Val Val

C22H38N6O5 (466.2904)

His Pro Ile Thr

C21H34N6O6 (466.254)

His Pro Leu Thr

C21H34N6O6 (466.254)

His Pro Thr Ile

C21H34N6O6 (466.254)

His Pro Thr Leu

C21H34N6O6 (466.254)

His Thr Ile Pro

C21H34N6O6 (466.254)

His Thr Leu Pro

C21H34N6O6 (466.254)

His Thr Pro Ile

C21H34N6O6 (466.254)

His Thr Pro Leu

C21H34N6O6 (466.254)

His Val Ile Val

C22H38N6O5 (466.2904)

His Val Leu Val

C22H38N6O5 (466.2904)

His Val Val Ile

C22H38N6O5 (466.2904)

His Val Val Leu

C22H38N6O5 (466.2904)

Ile Ala Thr Tyr

C22H34N4O7 (466.2427)

Ile Ala Tyr Thr

C22H34N4O7 (466.2427)

Ile Phe Ser Thr

C22H34N4O7 (466.2427)

Ile Phe Thr Ser

C22H34N4O7 (466.2427)

Ile His Pro Thr

C21H34N6O6 (466.254)

Ile His Thr Pro

C21H34N6O6 (466.254)

Ile His Val Val

C22H38N6O5 (466.2904)

Ile Pro His Thr

C21H34N6O6 (466.254)

Ile Pro Thr His

C21H34N6O6 (466.254)

Ile Ser Phe Thr

C22H34N4O7 (466.2427)

Ile Ser Thr Phe

C22H34N4O7 (466.2427)

Ile Thr Ala Tyr

C22H34N4O7 (466.2427)

Ile Thr Phe Ser

C22H34N4O7 (466.2427)

Ile Thr His Pro

C21H34N6O6 (466.254)

Ile Thr Pro His

C21H34N6O6 (466.254)

Ile Thr Ser Phe

C22H34N4O7 (466.2427)

Ile Thr Tyr Ala

C22H34N4O7 (466.2427)

Ile Val His Val

C22H38N6O5 (466.2904)

Ile Val Val His

C22H38N6O5 (466.2904)

Ile Tyr Ala Thr

C22H34N4O7 (466.2427)

Ile Tyr Thr Ala

C22H34N4O7 (466.2427)

Leu Ala Thr Tyr

C22H34N4O7 (466.2427)

Leu Ala Tyr Thr

C22H34N4O7 (466.2427)

Leu Phe Ser Thr

C22H34N4O7 (466.2427)

Leu Phe Thr Ser

C22H34N4O7 (466.2427)

Leu His Pro Thr

C21H34N6O6 (466.254)

Leu His Thr Pro

C21H34N6O6 (466.254)

Leu His Val Val

C22H38N6O5 (466.2904)

Leu Pro His Thr

C21H34N6O6 (466.254)

Leu Pro Thr His

C21H34N6O6 (466.254)

Leu Ser Phe Thr

C22H34N4O7 (466.2427)

Leu Ser Thr Phe

C22H34N4O7 (466.2427)

Leu Thr Ala Tyr

C22H34N4O7 (466.2427)

Leu Thr Phe Ser

C22H34N4O7 (466.2427)

Leu Thr His Pro

C21H34N6O6 (466.254)

Leu Thr Pro His

C21H34N6O6 (466.254)

Leu Thr Ser Phe

C22H34N4O7 (466.2427)

Leu Thr Tyr Ala

C22H34N4O7 (466.2427)

Leu Val His Val

C22H38N6O5 (466.2904)

Leu Val Val His

C22H38N6O5 (466.2904)

Leu Tyr Ala Thr

C22H34N4O7 (466.2427)

Leu Tyr Thr Ala

C22H34N4O7 (466.2427)

Pro His Ile Thr

C21H34N6O6 (466.254)

Pro His Leu Thr

C21H34N6O6 (466.254)

Pro His Thr Ile

C21H34N6O6 (466.254)

Pro His Thr Leu

C21H34N6O6 (466.254)

Pro Ile His Thr

C21H34N6O6 (466.254)

Pro Ile Thr His

C21H34N6O6 (466.254)

Pro Leu His Thr

C21H34N6O6 (466.254)

Pro Leu Thr His

C21H34N6O6 (466.254)

Pro Thr His Ile

C21H34N6O6 (466.254)

Pro Thr His Leu

C21H34N6O6 (466.254)

Pro Thr Ile His

C21H34N6O6 (466.254)

Pro Thr Leu His

C21H34N6O6 (466.254)

Ser Phe Ile Thr

C22H34N4O7 (466.2427)

Ser Phe Leu Thr

C22H34N4O7 (466.2427)

Ser Phe Thr Ile

C22H34N4O7 (466.2427)

Ser Phe Thr Leu

C22H34N4O7 (466.2427)

Ser Ile Phe Thr

C22H34N4O7 (466.2427)

Ser Ile Thr Phe

C22H34N4O7 (466.2427)

Ser Leu Phe Thr

C22H34N4O7 (466.2427)

Ser Leu Thr Phe

C22H34N4O7 (466.2427)

Ser Thr Phe Ile

C22H34N4O7 (466.2427)

Ser Thr Phe Leu

C22H34N4O7 (466.2427)

Ser Thr Ile Phe

C22H34N4O7 (466.2427)

Ser Thr Leu Phe

C22H34N4O7 (466.2427)

Ser Val Val Tyr

C22H34N4O7 (466.2427)

Ser Val Tyr Val

C22H34N4O7 (466.2427)

Ser Tyr Val Val

C22H34N4O7 (466.2427)

Thr Ala Ile Tyr

C22H34N4O7 (466.2427)

Thr Ala Leu Tyr

C22H34N4O7 (466.2427)

Thr Ala Tyr Ile

C22H34N4O7 (466.2427)

Thr Ala Tyr Leu

C22H34N4O7 (466.2427)

Thr Phe Ile Ser

C22H34N4O7 (466.2427)

Thr Phe Leu Ser

C22H34N4O7 (466.2427)

Thr Phe Ser Ile

C22H34N4O7 (466.2427)

Thr Phe Ser Leu

C22H34N4O7 (466.2427)

Thr Phe Thr Val

C22H34N4O7 (466.2427)

Thr Phe Val Thr

C22H34N4O7 (466.2427)

Thr His Ile Pro

C21H34N6O6 (466.254)

Thr His Leu Pro

C21H34N6O6 (466.254)

Thr His Pro Ile

C21H34N6O6 (466.254)

Thr His Pro Leu

C21H34N6O6 (466.254)

Thr Ile Ala Tyr

C22H34N4O7 (466.2427)

Thr Ile Phe Ser

C22H34N4O7 (466.2427)

Thr Ile His Pro

C21H34N6O6 (466.254)

Thr Ile Pro His

C21H34N6O6 (466.254)

Thr Ile Ser Phe

C22H34N4O7 (466.2427)

Thr Ile Tyr Ala

C22H34N4O7 (466.2427)

Thr Leu Ala Tyr

C22H34N4O7 (466.2427)

Thr Leu Phe Ser

C22H34N4O7 (466.2427)

Thr Leu His Pro

C21H34N6O6 (466.254)

Thr Leu Pro His

C21H34N6O6 (466.254)

Thr Leu Ser Phe

C22H34N4O7 (466.2427)

Thr Leu Tyr Ala

C22H34N4O7 (466.2427)

Thr Pro His Ile

C21H34N6O6 (466.254)

Thr Pro His Leu

C21H34N6O6 (466.254)

Thr Pro Ile His

C21H34N6O6 (466.254)

Thr Pro Leu His

C21H34N6O6 (466.254)

Thr Ser Phe Ile

C22H34N4O7 (466.2427)

Thr Ser Phe Leu

C22H34N4O7 (466.2427)

Thr Ser Ile Phe

C22H34N4O7 (466.2427)

Thr Ser Leu Phe

C22H34N4O7 (466.2427)

Thr Thr Phe Val

C22H34N4O7 (466.2427)

Thr Thr Val Phe

C22H34N4O7 (466.2427)

Thr Val Phe Thr

C22H34N4O7 (466.2427)

Thr Val Thr Phe

C22H34N4O7 (466.2427)

Thr Tyr Ala Ile

C22H34N4O7 (466.2427)

Thr Tyr Ala Leu

C22H34N4O7 (466.2427)

Thr Tyr Ile Ala

C22H34N4O7 (466.2427)

Thr Tyr Leu Ala

C22H34N4O7 (466.2427)

Val Phe Thr Thr

C22H34N4O7 (466.2427)

Val His Ile Val

C22H38N6O5 (466.2904)

Val His Leu Val

C22H38N6O5 (466.2904)

Val His Val Ile

C22H38N6O5 (466.2904)

Val His Val Leu

C22H38N6O5 (466.2904)

Val Ile His Val

C22H38N6O5 (466.2904)

Val Ile Val His

C22H38N6O5 (466.2904)

Val Leu His Val

C22H38N6O5 (466.2904)

Val Leu Val His

C22H38N6O5 (466.2904)

Val Ser Val Tyr

C22H34N4O7 (466.2427)

Val Ser Tyr Val

C22H34N4O7 (466.2427)

Val Thr Phe Thr

C22H34N4O7 (466.2427)

Val Thr Thr Phe

C22H34N4O7 (466.2427)

Val Val His Ile

C22H38N6O5 (466.2904)

Val Val His Leu

C22H38N6O5 (466.2904)

Val Val Ile His

C22H38N6O5 (466.2904)

Val Val Leu His

C22H38N6O5 (466.2904)

Val Val Ser Tyr

C22H34N4O7 (466.2427)

Val Val Tyr Ser

C22H34N4O7 (466.2427)

Val Tyr Ser Val

C22H34N4O7 (466.2427)

Val Tyr Val Ser

C22H34N4O7 (466.2427)

Tyr Ala Ile Thr

C22H34N4O7 (466.2427)

Tyr Ala Leu Thr

C22H34N4O7 (466.2427)

Tyr Ala Thr Ile

C22H34N4O7 (466.2427)

Tyr Ala Thr Leu

C22H34N4O7 (466.2427)

Tyr Ile Ala Thr

C22H34N4O7 (466.2427)

Tyr Ile Thr Ala

C22H34N4O7 (466.2427)

Tyr Leu Ala Thr

C22H34N4O7 (466.2427)

Tyr Leu Thr Ala

C22H34N4O7 (466.2427)

Tyr Ser Val Val

C22H34N4O7 (466.2427)

Tyr Thr Ala Ile

C22H34N4O7 (466.2427)

Tyr Thr Ala Leu

C22H34N4O7 (466.2427)

Tyr Thr Ile Ala

C22H34N4O7 (466.2427)

Tyr Thr Leu Ala

C22H34N4O7 (466.2427)

Tyr Val Ser Val

C22H34N4O7 (466.2427)

Tyr Val Val Ser

C22H34N4O7 (466.2427)

(24RS)-28,28,28-trifluoro-25-hydroxyvitamin D2 / (24RS)-28,28,28-trifluoro-25-hydroxyergocalciferol

C28H41F3O2 (466.3058)

(5Z,7E)-(1S,3R)-24-(dimethoxyphosphoryl)-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C26H43O5P (466.2848)

3α-hydroxy-5α-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)

5-alpha-Dihydrotestosterone glucuronide

C25H38O8 (466.2567)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

3alpha-Hydroxy-5alpha-androstane-17-one 3-D-glucuronoside

C25H38O8 (466.2567)

PA(20:0/0:0)

C23H47O7P (466.3059)

3alpha-hydroxy-5alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)

6-Bromo-5E,9Z,13Z,24Z-heptacosatetraenoic acid

C26H43BrO2 (466.2446)

Sarcoehrendin F

C25H38O8 (466.2567)

glas#10

C21H38O11 (466.2414)

An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#10 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.

ST 29:7;O5

C29H38O5 (466.2719)

(24RS)-28,28,28-trifluoro-25-hydroxyvitamin D2

C28H41O2F3 (466.3058)

1alpha-hydroxy-24-(dimethoxyphosphoryl)-25,26,27-trinorvitamin D3

C26H43O5P (466.2848)

ST 19:1;O2;GlcA

C25H38O8 (466.2567)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

butyl prop-2-enoate,2-methylprop-2-enoic acid,propane-1,2-diol,prop-2-enoic acid,styrene

C25H38O8 (466.2567)

Trefentanil

C25H31FN6O2 (466.2492)

C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

3,3-(Ethane-1,2-diylbis(oxy))bis(3,1-phenylene)diboronic acid, pinacol ester

C26H36B2O6 (466.2698)

N-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol

C24H39ClN4O3 (466.2711)

Febuverine

C28H38N2O4 (466.2831)

1-BENZYL-1,6-DIAZASPIRO[3.3]HEPTANE

C26H34N4O4 (466.258)

RuPhos

C30H43O2P (466.3001)

1-O-{(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoyl}-beta-D-glucopyranose

C21H38O11 (466.2414)

5-S-[2-(Decylamino)ethyl]-5-Thioadenosine

C22H38N6O3S (466.2726)

[[Cyclohexanesulfonyl-glycyl]-3[pyridin-4-YL-aminomethyl]alanyl]piperidine

C22H36N5O4S+ (466.2488)

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase.

5alpha-Androstan-17beta-ol-3-one glucosiduronate

C25H38O8 (466.2567)

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C25H38O8 (466.2567)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

C25H38O8 (466.2567)

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H38O8 (466.2567)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

C25H38O8 (466.2567)

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.2933)

Etiocholanolone 3-glucuronide

C25H38O8 (466.2567)

A steroid glucosiduronic acid having etiocholanolone as the steroid component.

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)

N-(1-Cyclohexylcarbamoyl-cyclopentyl)-N-(5-methyl-isoxazol-3-yl)-N-phenyl-succinamide

C26H34N4O4 (466.258)

Phe-Gly-Leu-Met-NH2(1+)

C22H36N5O4S+ (466.2488)

(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

Glucosyl-6beta-hydroxytestosterone

C25H38O8 (466.2567)

A steroid saponin that is 6beta-hydroxytestosterone attached to a alpha-D-glucopyranosyl residue at position 6 via glycosidic linkage.

Methyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-L-leucinate

C27H34N2O5 (466.2468)

3,5,7-Trimethyl-1-adamantanecarboxylic acid 2-(4-methyl-3-phenacyl-5-thiazol-3-iumyl)ethyl ester

C28H36NO3S+ (466.2416)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide

C26H34N4O4 (466.258)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide

C26H34N4O4 (466.258)

(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(oxan-4-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol

C24H38N2O5S (466.2501)

(2S,3R,12bS)-3-ethenyl-2-[[(1R)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) decanoate

C22H43O8P (466.2695)

2,3-dihydroxypropyl [3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate

C22H43O8P (466.2695)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexadecanoate

C22H43O8P (466.2695)

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C22H43O8P (466.2695)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate

C22H43O8P (466.2695)

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) undecanoate

C22H43O8P (466.2695)

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate

C22H43O8P (466.2695)

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) dodecanoate

C22H43O8P (466.2695)

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

C22H43O8P (466.2695)

7-Tert-butyl-7-(2,4,6-triisopropylphenyl)-2,3,5,6-dibenzo-7-silanorbornadiene

C33H42Si (466.3056)

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.2933)

N-[(E,4Z,7R)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2H-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-enyl]-N-methylacetamide

C25H39ClN2O4 (466.2598)

2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C22H45NO7P+ (466.2933)

Androsterone glucuronide

C25H38O8 (466.2567)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Etiocholanolone glucuronide

C25H38O8 (466.2567)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

desmethylemetine

C28H38N2O4 (466.2831)

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)

Hirsutalin H, (rel)-

C26H42O7 (466.293)

A natural product found in Cladiella hirsuta.

5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)

C25H38O8 (466.2567)

A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17.

androsterone 3-glucosiduronic acid

C25H38O8 (466.2567)

A steroid glucosiduronic acid having androsterone as the steroid component.

3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid

C25H38O8 (466.2567)

PA 15:0/4:0

C22H43O8P (466.2695)

PA 17:0/2:0

C22H43O8P (466.2695)

PA 19:0

C22H43O8P (466.2695)

LPG O-16:2

C22H43O8P (466.2695)

LPG P-16:1

C22H43O8P (466.2695)

LPG P-16:1 or LPG O-16:2

C22H43O8P (466.2695)

ST 20:0;O;GlcA

C26H42O7 (466.293)

ST 19:2;O3;Hex

C25H38O8 (466.2567)

ST 20:1;O2;Hex

C26H42O7 (466.293)

ST 26:2;O2;S

C26H42O5S (466.2753)

ST 25:3;O8

C25H38O8 (466.2567)

ST 26:2;O7

C26H42O7 (466.293)

LP-211

C30H34N4O (466.2732)

LP-211 is a selective and blood?brain barrier penetrant 5-HT7 receptor agonist, with a Ki of 0.58 nM, with high selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM).

Mutant IDH1 inhibitor

C25H34N6O3 (466.2692)

Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM.

3-hydroxy-5-{[4-hydroxy-1-(2-hydroxypropan-2-yl)-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-methyl-5-oxopentanoic acid

C26H42O7 (466.293)

4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)

6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

C29H38O5 (466.2719)

(1s,2s,3s,6s,7s,8s,9s,12r)-12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.293)

(1r,2r,4as,5'r,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)

6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)

1-[(1s,2s)-1,2-bis(acetyloxy)-5-oxocyclopent-3-en-1-yl]pentadecyl acetate

C26H42O7 (466.293)

methyl 2-(5-hydroxy-2-{[(6e)-3-methyl-7-{[(1r,5r)-3-methyl-5-(2-methylprop-1-en-1-yl)-4-oxocyclopent-2-en-1-yl]methyl}octa-1,6-dien-3-yl]oxy}phenyl)acetate

C29H38O5 (466.2719)

(3s,3as,6as,9s,10r)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)

(1r,2r,2''s,4r,4as,5's,6s,8as)-2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C25H38O8 (466.2567)

(3s,5s)-5,6-dihydroxy-2-[(1r,3r,4s,5s,6s)-5-hydroxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

C25H38O8 (466.2567)

14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl butanoate

C26H42O7 (466.293)

12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.293)

(2r,3r,4s,5s,6r)-2-{[(2e)-7-hydroxy-3,7-dimethyloct-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C21H38O11 (466.2414)

16-kaurene-2,15-diol; (ent-2α,15β)-form,2-o-beta-d-glucopyranoside

C26H42O7 (466.293)

{"Ingredient_id": "HBIN001924","Ingredient_name": "16-kaurene-2,15-diol; (ent-2\u03b1,15\u03b2)-form,2-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H42O7","Ingredient_Smile": "NA","Ingredient_weight": "466.61","OB_score": "NA","CAS_id": "34336-00-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9266","PubChem_id": "NA","DrugBank_id": "NA"}

4,5,6-tri-o-acetylhygrophorone b14

C26H42O7 (466.293)

{"Ingredient_id": "HBIN009980","Ingredient_name": "4,5,6-tri-o-acetylhygrophorone b14","Alias": "NA","Ingredient_formula": "C26H42O7","Ingredient_Smile": "CCCCCCCCCCCCCCC(C1(C(C=CC1=O)OC(=O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "466.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21520","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11271282","DrugBank_id": "NA"}

6,7-dihydroxy-n-(2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl)octa-2,4-dienamide

C23H38N4O6 (466.2791)

(1s,2r,4as,5's,5''s,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)

2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C25H38O8 (466.2567)

(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-methoxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C25H38O8 (466.2567)

(1s,2r,5s,7s,10s,11s,13s,14r,17s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)

(2r,3s,4r,5s,6r)-2-{[(1s,2s,4ar,4bs,7s,10ar)-7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H42O7 (466.293)

3-(acetyloxy)-5,12-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H42O7 (466.293)

1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

C25H38O8 (466.2567)

n-[(4z,7r,8z)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)

10-(acetyloxy)-3a,3b,7-trihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C25H38O8 (466.2567)

8-isopropyl-12-methoxy-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-5,10,13-trien-2-yl 3-(1-methylimidazol-4-yl)prop-2-enoate

C28H38N2O4 (466.2831)

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)

(1s,3ar,3bs,7s,9ar,9bs,10s,11s,11as)-10-(acetyloxy)-3a,3b,7-trihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C25H38O8 (466.2567)

methyl 5-methoxy-12-{1-[(3-methylbut-2-enoyl)oxy]ethyl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C27H34N2O5 (466.2468)

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)

(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

C29H38O5 (466.2719)

(1r,2r,3r,6r,7r,8r,9r,12s)-12-(acetyloxy)-1,9-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.293)

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

C30H34N4O (466.2732)

(1z,5e,7r,9r,10s,13r,14r,16z,18e,24s,25s)-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁷,¹⁴.0⁹,¹³]octacosa-1,5,11,16,18,20,26-heptaen-28-one

C27H34N2O5 (466.2468)

2-hydroxy-3-({6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl}methyl)-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one

C27H38N4O3 (466.2944)

methyl (1r,12r,19r)-5-methoxy-12-[(1s)-1-[(3-methylbut-2-enoyl)oxy]ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C27H34N2O5 (466.2468)

(2r,4as,6as,12br,14as,14br)-11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C29H38O5 (466.2719)

(1r,2s,3r,5r,6r,7r,8r,9r,13s)-3-(acetyloxy)-5-hydroxy-6-isopropyl-3,9,13-trimethyl-12-oxo-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H42O7 (466.293)

(2r,4ar,5r,8as)-1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

C29H38O5 (466.2719)

(2s,3r,4s,5s,6r)-2-{[(1s,2s,4ar,4bs,7s,10ar)-7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H42O7 (466.293)

(2r,3r)-1-[(1r,2r,4as,8ar)-2-(acetyloxy)-8a-[(acetyloxy)methyl]-2,5,5-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C26H42O7 (466.293)

1-[1,2-bis(acetyloxy)-5-oxocyclopent-3-en-1-yl]pentadecyl acetate

C26H42O7 (466.293)

1-{3,4-dihydroxy-5-[({3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl}-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)

(1s,2s,3s,5r,7s,8s,10r,11r,14s)-14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl butanoate

C26H42O7 (466.293)

(1s,2s,4s,5r,6s,11r,14r,15s,18s,22r,23r)-9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

C29H38O5 (466.2719)

(1s,3r,6s,8s)-1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

C25H38O8 (466.2567)

7-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

C29H38O5 (466.2719)

11-hydroxy-9-(hydroxymethyl)-10-methoxy-2,4a,6a,12b,14a-pentamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C29H38O5 (466.2719)

(2s,3z,12br)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-11-ol

C30H34N4O (466.2732)

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C29H38O5 (466.2719)

methyl 6-[1-hydroxy-3-methoxy-2-(6-methyloctyl)-3-oxopropyl]phenazine-1-carboxylate

C27H34N2O5 (466.2468)

(1r,2r,3r,5s,7r,8r,10s,11s,14s)-14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl butanoate

C26H42O7 (466.293)

9-(acetyloxy)-5,12-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H42O7 (466.293)

(3r)-5-{[(1r,3as,4s,12as)-4-hydroxy-1-(2-hydroxypropan-2-yl)-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C26H42O7 (466.293)

n-[(4z,8z)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-[({3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl}oxy)methyl]oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)

4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl 2-hydroxydecanoate

C25H38O8 (466.2567)

2-[(7-hydroxy-3,7-dimethyloct-2-en-1-yl)oxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C21H38O11 (466.2414)

methyl 6-[(1s,2r)-1-hydroxy-3-methoxy-2-(7-methyloctyl)-3-oxopropyl]phenazine-1-carboxylate

C27H34N2O5 (466.2468)

(6r)-6-[(1s,4s,4as,8ar)-4,7-dimethyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4a,5,6,8a-hexahydro-1h-naphthalen-1-yl]-2-methylhept-1-en-3-one

C26H42O7 (466.293)

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl (2r)-2-hydroxydecanoate

C25H38O8 (466.2567)

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)

(z)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)

(1r,2s,3r,5r,6r,7r,8r,9r,12s)-3-(acetyloxy)-5,12-dihydroxy-6-isopropyl-3,9-dimethyl-13-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H42O7 (466.293)

(18e)-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁷,¹⁴.0⁹,¹³]octacosa-1,5,11,16,18,20,26-heptaen-28-one

C27H34N2O5 (466.2468)

n-[(4z,8e)-4-(chloromethylidene)-10-[3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)

(2e,4e)-6,7-dihydroxy-n-[(3s,6s,9s)-2-hydroxy-6-isopropyl-3,4,7-trimethyl-5,8-dioxo-1,4,7-triazacyclododec-1-en-9-yl]octa-2,4-dienimidic acid

C23H38N4O6 (466.2791)

(1s,4s,6r,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2r,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]-2-methylundeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H38O5 (466.2719)

1,1,4a-trimethyl-6-methylidene-5-{[(2-oxochromen-7-yl)oxy]methyl}-hexahydro-2h-naphthalen-2-yl 3-methylbutanoate

C29H38O5 (466.2719)

(2r)-n-[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C22H38N6O5 (466.2904)

4-hydroxy-10,11-dimethyl-7-methylidene-2,5-dioxatetracyclo[8.4.0.0¹,³.0⁴,⁸]tetradecan-14-yl 2-hydroxy-2-(hydroxymethyl)-4,6-dimethyloctanoate

C26H42O7 (466.293)

(1r)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol

C28H38N2O4 (466.2831)

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C29H38O5 (466.2719)

11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)

methyl (2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

C29H38O5 (466.2719)

3-(acetyloxy)-5-hydroxy-6-isopropyl-3,9,13-trimethyl-12-oxo-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H42O7 (466.293)

1-[(2r,3s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)

(3r,5r)-2,5-dihydroxy-6-[(1s,3s,4r,5r,6s)-4-hydroxy-6-methyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-2-methylhept-6-en-3-yl (2z)-2-methylbut-2-enoate

C25H38O8 (466.2567)

(6s,7r,10e)-6-hydroxy-2,6,10-trimethyl-13-(7-methyl-5,8-dioxonaphthalen-2-yl)trideca-2,10-dien-7-yl acetate

C29H38O5 (466.2719)

(1s,2s,4r,6s,7s,8s,9r,12r,13s)-4-(acetyloxy)-12,13-dihydroxy-6-isopropyl-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H42O7 (466.293)

(2r,3s,4s,5s,6r)-2-{[(1s,2s,4ar,4bs,7s,10ar)-7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H42O7 (466.293)

(1s,2r,5s,7s,10s,11s,13s,14r,17s,18s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)

(2r)-2-{2-[(1r,2s,3r,4ar,8ar)-5-[(acetyloxy)methyl]-3-hydroxy-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-(acetyloxy)butyl acetate

C26H42O7 (466.293)

(2s,3z,12bs)-3-ethylidene-9-methoxy-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C30H34N4O (466.2732)

4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl tetradecanoate

C29H38O5 (466.2719)

methyl 6-[(1s,2r)-1-hydroxy-3-methoxy-2-(6-methyloctyl)-3-oxopropyl]phenazine-1-carboxylate

C27H34N2O5 (466.2468)

(1s,2r,4as,5's,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H34N4O (466.2732)

(2r,3r,4s,5s,6r)-2-{[(1r,4r,7r,9r,10s,13r,15s)-15-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H42O7 (466.293)

3-ethenyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)

(2s)-n-[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C22H38N6O5 (466.2904)

methyl 6-[1-hydroxy-3-methoxy-2-(7-methyloctyl)-3-oxopropyl]phenazine-1-carboxylate

C27H34N2O5 (466.2468)

1-({3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol

C28H38N2O4 (466.2831)

n-[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C22H38N6O5 (466.2904)

(2s,3r,12bs)-3-ethenyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H34N4O (466.2732)

(1s)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C28H38N2O4 (466.2831)

2,5-dihydroxy-6-{4-hydroxy-6-methyl-5-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-2-methylhept-6-en-3-yl 2-methylbut-2-enoate

C25H38O8 (466.2567)

2-[(7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H42O7 (466.293)

(1s,2r,6s,7r,9r,11s,12s,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,11,16-trimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C29H38O5 (466.2719)

5,6-dihydroxy-2-{5-hydroxy-6-methyl-4-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-6-methylhept-1-en-3-yl 2-methylbut-2-enoate

C25H38O8 (466.2567)

(1r,2r,3r,9r,10r)-2-hydroxy-3-{[(1r,9s)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]methyl}-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-6-one

C27H38N4O3 (466.2944)

(e)-(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalene-1-carbonyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H38O5 (466.2719)

6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)

n-[(4z,7r,8e)-4-(chloromethylidene)-10-[(2s)-3-methoxy-2-(2-methylpropyl)-5-oxo-2h-pyrrol-1-yl]-7,9-dimethyl-10-oxodec-8-en-1-yl]-n-methylacetamide

C25H39ClN2O4 (466.2598)

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)

1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-({[(2e)-3-methyl-5-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]pent-2-en-1-yl]oxy}methyl)oxolan-2-yl]-4-hydroxy-5,6-dihydropyrimidin-2-one

C24H38N2O7 (466.2679)

(3s)-5-{[(1r,3as,4s,12as)-4-hydroxy-1-(2-hydroxypropan-2-yl)-3a,10-dimethyl-1h,2h,3h,4h,7h,8h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C26H42O7 (466.293)

(3r,3ar,6ar,9r,10s,10as)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2r)-2-hydroxydecanoate

C25H38O8 (466.2567)

1-[2-(acetyloxy)-8a-[(acetyloxy)methyl]-2,5,5-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C26H42O7 (466.293)

(1s,2s,4r,8r,9s,10z,12r)-8-isopropyl-12-methoxy-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-5,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C28H38N2O4 (466.2831)

9-hydroxy-6,10,14,15,22-pentamethyl-21-methylidene-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacos-9-ene-8,25-dione

C29H38O5 (466.2719)

methyl 10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate

C29H38O5 (466.2719)

(1e,5e,16z,18e)-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁷,¹⁴.0⁹,¹³]octacosa-1,5,11,16,18,20,26-heptaen-28-one

C27H34N2O5 (466.2468)

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione

C29H38O5 (466.2719)

n-{1-[(2r,5s,6r)-5-{[(4s,5s,6r)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbutanamide

C23H38N4O6 (466.2791)

4-(acetyloxy)-2-(2-{5-[(acetyloxy)methyl]-3-hydroxy-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}ethyl)butyl acetate

C26H42O7 (466.293)